Summit Creek Advisors LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 300 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 2.62 and the average weighting 0.4%.

Quarter-by-quarter ownership
Summit Creek Advisors LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$7,441,000
-1.2%
74,822
-5.3%
0.96%
-14.5%
Q3 2020$7,529,000
-22.1%
78,982
-8.6%
1.12%
-21.6%
Q2 2020$9,666,000
+88.3%
86,422
+22.4%
1.42%
+38.8%
Q1 2020$5,133,000
-30.6%
70,582
-0.5%
1.03%
-11.3%
Q4 2019$7,401,000
+4.2%
70,962
-0.6%
1.16%
-2.9%
Q3 2019$7,103,000
-9.5%
71,362
+3.8%
1.19%
-9.6%
Q2 2019$7,847,000
+31.2%
68,742
+44.5%
1.32%
+23.5%
Q1 2019$5,980,000
-7.5%
47,572
-0.2%
1.07%
-18.5%
Q4 2018$6,466,000
-16.2%
47,652
+69.6%
1.31%
+5.9%
Q3 2018$7,712,000
-26.1%
28,097
-44.2%
1.24%
-34.1%
Q2 2018$10,439,000
+14.7%
50,387
-8.5%
1.88%
+13.3%
Q1 2018$9,098,000
+56.1%
55,087
+29.4%
1.66%
+51.1%
Q4 2017$5,830,000
-0.2%
42,577
-0.7%
1.10%
-4.8%
Q3 2017$5,840,000
+11.3%
42,892
-0.8%
1.15%
+6.4%
Q2 2017$5,247,000
+6.0%
43,217
-7.6%
1.08%
+4.0%
Q1 2017$4,950,000
-21.0%
46,772
-24.1%
1.04%
-3.1%
Q4 2016$6,264,000
-58.9%
61,647
-58.7%
1.07%
-57.1%
Q3 2016$15,250,000
+8.1%
149,422
+26.3%
2.50%
+4.3%
Q2 2016$14,106,000
+4.4%
118,272
-6.3%
2.40%
+12.7%
Q1 2016$13,514,000
+55.7%
126,197
+57.7%
2.13%
+46.6%
Q4 2015$8,677,000
+43.4%
80,035
+13.3%
1.45%
+47.7%
Q3 2015$6,050,00070,6320.98%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
KNOTT DAVID M 353,041$36,819,00014.92%
CARDINAL CAPITAL MANAGEMENT LLC /CT 919,994$95,946,0002.93%
Elk Creek Partners, LLC 236,862$24,702,0002.84%
Conestoga Capital Advisors, LLC 619,653$64,624,0001.56%
WOODSTOCK CORP 71,489$7,456,0001.21%
Summit Creek Advisors LLC 70,962$7,401,0001.16%
FALCON POINT CAPITAL, LLC 8,115$846,0001.08%
RICE HALL JAMES & ASSOCIATES, LLC 302,503$31,548,0001.07%
Stephens Investment Management Group LLC 508,100$52,990,0001.00%
Tygh Capital Management, Inc. 55,672$5,806,0000.96%
View complete list of LIGAND PHARMACEUTICALS INC shareholders